Fresh Recalls

FDAClass II · Drug · Recall D-0745-2026 · Recalled August 12, 2026

Mirabegron Extended-Release Tablets recall — Zydus Pharmaceuticals (USA) Inc

Agency report date: August 12, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Mirabegron Extended-Release Tablets
Company / brand
Zydus Pharmaceuticals (USA)
Lot / serial / date codes
Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3
Distribution
Nationwide in the USA
Agency product description and boundaries

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Mirabegron Extended-Release Tablets

3. Open the official notice or contact

Official recall ID
D-0745-2026
Brand
Zydus Pharmaceuticals (USA)
Classification
Class II
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Pennington, NJ, United States
Firm address
73 Route 31 N, 08534-3601

Identifying details (verbatim from the notice)

Product codes / lots
Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
99563
Recall initiated
August 5, 2026
FDA classified
August 7, 2026
FDA report date
August 12, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page